0001599298-22-000034.txt : 20220426
0001599298-22-000034.hdr.sgml : 20220426
20220426163658
ACCESSION NUMBER: 0001599298-22-000034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220425
FILED AS OF DATE: 20220426
DATE AS OF CHANGE: 20220426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gayko Urte
CENTRAL INDEX KEY: 0001559217
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36866
FILM NUMBER: 22854881
MAIL ADDRESS:
STREET 1: C/O PARMACYCLICS, INC.
STREET 2: 995 EAST ARQUES AVENUE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Summit Therapeutics Inc.
CENTRAL INDEX KEY: 0001599298
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BROADWAY
STREET 2: 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-514-7149
MAIL ADDRESS:
STREET 1: ONE BROADWAY
STREET 2: 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Therapeutics plc
DATE OF NAME CHANGE: 20150219
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Corp plc
DATE OF NAME CHANGE: 20140205
4
1
wf-form4_165100539719830.xml
FORM 4
X0306
4
2022-04-25
0
0001599298
Summit Therapeutics Inc.
SMMT
0001559217
Gayko Urte
C/O SUMMIT THERAPEUTICS INC.
ONE BROADWAY, 14TH FLOOR
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (right to buy)
1.93
2022-04-25
4
A
0
400000
A
2032-04-25
Common Stock
400000.0
400000
D
The option was granted on April 25, 2022. The shares underlying the option are scheduled to vest in four equal annual installments over four years.
Not applicable.
/s/ Urte Gayko
2022-04-26